新冠肺炎背景下静脉用药集中调配应急管理模式构建

Construction of emergency management mode of pharmacy intravenous admixture under the background of COVID-19

新型冠状病毒肺炎(COVID-19)暴发后,由于隔离病区环境污染及防护服等导致操作受限等因素,定点收治医院的静脉用药应集中配置。结合现有流程,对我院静脉用药配置中心流程进行优化,调整操作台操作模式,优化排班机制,探索并制定"一审五核对"的节点控制流程,以满足COVID-19患者24 h静脉用药需求;结合新冠病毒药物治疗特点,调整处方审核重点,保障患者用药安全;推行无纸化处方,减少不必要的传播媒介;实行分段式输液配送管理,确保无交叉感染;分级分区管控配置环境,加强药师防护管理,规避人员感染风险;优化人力资源配置,提高工作效率。本次流程重组及优化构建了COVID-19背景下静脉用药集中调配应急管理模式,保障了COVID-19患者静脉用药需求和安全,救治工作有序进行,为今后医疗机构药学部门应对突发重大公共卫生事件提供参考。

After the outbreak of COVID-19,due to environmental pollution in the isolated ward and operational constraints caused by protective clothing and other factors,intravenous drugs in the designated hospitals should be centralized.Combined with the existing process mode,the process of pharmacy intravenous admixture services was optimized,the operation mode of the operation platform was adjusted,the scheduling mechanism was optimized,and the node control process of"first verify and five checks"was explored and developed,so as to meet the 24 h needs of COVID-19 patients.According to the characteristics of COVID-19 drug treatment,the focus of prescription review was adjusted to ensure the drug safety of patients.Other measures included implementing paperless prescription to reduce unnecessary media;implementing segmented infusion distribution management to ensure no cross infection;hierarchical control and configuration environment,strengthening the protection and management of pharmacists,to avoid the risk of personnel infection;optimizing human resource allocation and improving work efficiency.This process reengineering and optimization established the emergency management mode of centralized intravenous drug deployment under the background of COVID-19,which ensured the intravenous drug demand and safety of COVID-19 patients.The treatment work was carried out orderly,and could provide reference for the pharmaceutical department in medical institutions to deal with major public health emergencies in the future.